Company Overview
AptarGroup, Inc. designs and manufactures comprehensive solutions including drug delivery systems, consumer product dispensing mechanisms, and active material science services for diverse markets such as pharmaceuticals, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage. The company operates within the Healthcare sector, specifically focused on the Medical Instruments & Supplies industry, where it provides specialized packaging and dispensing technologies essential for product safety and consumer experience. This entity maintains a substantial operational scale, evidenced by a market capitalization of $7.85B and a trailing twelve-month revenue of $3.78B, while employing a workforce of 14,000 individuals across its global footprint. The combination of a nearly $8 billion market cap and revenue approaching $4 billion indicates that AptarGroup holds a significant position as a large-cap player, suggesting deep market penetration and the capacity to influence industry standards within its specialized niches.
Financial Health
The company reported a trailing twelve-month revenue of $3.78B with a corresponding net income of $392.79M and EBITDA of $803.58M, revealing a cost structure where operating expenses and taxes consume approximately 79% of the generated revenue before reaching the bottom line. Free cash flow stands at $205.90M, which demonstrates that the business generates positive cash after capital expenditures, providing financial flexibility to service debt, fund operations, or return capital to shareholders without relying on external financing. Profitability is segmented across three key margins: a gross margin of 37.2% indicates healthy pricing power and manufacturing efficiency, an operating margin of 11.3% reflects effective control over administrative and selling expenses, and a profit margin of 10.4% shows the final return after all costs and taxes are deducted. Regarding leverage, the company holds $409.53M in cash against $1.55B in total debt, resulting in a debt-to-equity ratio of 57.10, which suggests a moderately leveraged balance sheet rather than a highly conservative or risk-free position. Short-term liquidity is supported by a current ratio of 1.62, indicating that the company possesses sufficient current assets to cover its current liabilities with a comfortable buffer. Finally, return metrics show a return on equity of 15.1% and a return on assets of 6.7%, implying that management is utilizing shareholder equity effectively to generate returns, though the return on assets suggests that the company's asset base is larger than its equity, consistent with its leveraged capital structure.
Valuation Assessment
Valuation metrics for AptarGroup include a trailing P/E ratio of 20.71 and a forward P/E of 19.09, where the lower forward multiple implies that the market expects earnings to stabilize or grow in the future compared to the historical average. The price-to-book ratio is 2.94, indicating that the stock trades at a significant premium over its book value, likely reflecting the intangible value of its proprietary designs and strong market position in specialized dispensing. Alternative valuation measures such as a price-to-sales ratio of 2.08 and an EV/EBITDA of 11.25 provide context by showing that the company is valued relative to its sales and cash earnings, suggesting a valuation that is reasonable for a firm in its specific industrial niche. Price action is bounded by a 52-week high of $164.28 and a 52-week low of $103.23, and while the exact current price is not provided in the facts, the forward P/E of 19.09 is notably lower than the trailing P/E of 20.71, suggesting potential re-rating potential if earnings improve. The stock exhibits a beta of 0.44, which signifies that the share price is less volatile than the broader market, moving only about 44% as much as the market index during periods of fluctuation.
Growth & Income
Revenue growth over the last year was 13.5%, while earnings growth declined by 23.5%, indicating that earnings are currently growing significantly slower than revenue, likely due to higher tax rates or increased operating costs compressing the bottom line despite top-line expansion. As a dividend payer, the company offers a yield of 1.5% with a payout ratio of 31.1%, a figure that appears sustainable given that the payout consumes only a fraction of the net income, leaving ample room for retention. The low payout ratio combined with the current financial position suggests that the company retains the majority of its earnings to reinvest into R&D, capacity expansion, or debt reduction rather than distributing them fully as dividends. Overall, the growth and income profile presents a scenario of top-line expansion that has not yet fully translated into earnings growth, supported by a sustainable dividend yield and a low-beta risk profile that may appeal to income-focused investors seeking stability.